These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 15653823)
21. Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis. Kennedy PGE; Rodgers J Front Immunol; 2019; 10():39. PubMed ID: 30740102 [TBL] [Abstract][Full Text] [Related]
22. A multi-centre evaluation of the card indirect agglutination test for trypanosomiasis (TrypTect CIATT). Asonganyi T; Doua F; Kibona SN; Nyasulu YM; Masake R; Kuzoe F Ann Trop Med Parasitol; 1998 Dec; 92(8):837-44. PubMed ID: 10396343 [TBL] [Abstract][Full Text] [Related]
23. Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness). Kennedy PG Lancet Neurol; 2013 Feb; 12(2):186-94. PubMed ID: 23260189 [TBL] [Abstract][Full Text] [Related]
24. The continuing problem of human African trypanosomiasis (sleeping sickness). Kennedy PG Ann Neurol; 2008 Aug; 64(2):116-26. PubMed ID: 18756506 [TBL] [Abstract][Full Text] [Related]
25. Comparison between bloodstream and procyclic form trypanosomes for serological diagnosis of African human trypanosomiasis. Katende JM; Nantulya VM; Musoke AJ Trans R Soc Trop Med Hyg; 1987; 81(4):607-8. PubMed ID: 3328347 [TBL] [Abstract][Full Text] [Related]
26. Priorities for the elimination of sleeping sickness. Welburn SC; Maudlin I Adv Parasitol; 2012; 79():299-337. PubMed ID: 22726645 [TBL] [Abstract][Full Text] [Related]
27. Improved latex agglutination test for detection of antibodies in serum and cerebrospinal fluid of Trypanosoma brucei gambiense infected patients. Büscher P; Lejon V; Magnus E; Van Meirvenne N Acta Trop; 1999 May; 73(1):11-20. PubMed ID: 10379812 [TBL] [Abstract][Full Text] [Related]
28. Factors influencing passive surveillance for T. b. rhodesiense human african trypanosomiasis in Uganda. Acup C; Bardosh KL; Picozzi K; Waiswa C; Welburn SC Acta Trop; 2017 Jan; 165():230-239. PubMed ID: 27212706 [TBL] [Abstract][Full Text] [Related]
29. Stage determination and therapeutic decision in human African trypanosomiasis: value of polymerase chain reaction and immunoglobulin M quantification on the cerebrospinal fluid of sleeping sickness patients in Côte d'Ivoire. Jamonneau V; Solano P; Garcia A; Lejon V; Djé N; Miezan TW; N'Guessan P; Cuny G; Büscher P Trop Med Int Health; 2003 Jul; 8(7):589-94. PubMed ID: 12828540 [TBL] [Abstract][Full Text] [Related]
30. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review). Gehrig S; Efferth T Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846 [TBL] [Abstract][Full Text] [Related]
31. Phase II evaluation of sensitivity and specificity of PCR and NASBA followed by oligochromatography for diagnosis of human African trypanosomiasis in clinical samples from D.R. Congo and Uganda. Matovu E; Mugasa CM; Ekangu RA; Deborggraeve S; Lubega GW; Laurent T; Schoone GJ; Schallig HD; Büscher P PLoS Negl Trop Dis; 2010 Jul; 4(7):e737. PubMed ID: 20625557 [TBL] [Abstract][Full Text] [Related]
32. [Value of molecular biology in the identification of trypanosomes responsible for African trypanosomiasis or sleeping sickness]. Truc P; Cuny G Med Trop (Mars); 2000; 60(2):115-9. PubMed ID: 11100432 [No Abstract] [Full Text] [Related]
33. Impact of mass chemotherapy in domestic livestock for control of zoonotic T. b. rhodesiense human African trypanosomiasis in Eastern Uganda. Fyfe J; Picozzi K; Waiswa C; Bardosh KL; Welburn SC Acta Trop; 2017 Jan; 165():216-229. PubMed ID: 27570206 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of the micro-CATT, CATT/Trypanosoma brucei gambiense, and LATEX/T b gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in West and Central Africa. Truc P; Lejon V; Magnus E; Jamonneau V; Nangouma A; Verloo D; Penchenier L; Büscher P Bull World Health Organ; 2002; 80(11):882-6. PubMed ID: 12481210 [TBL] [Abstract][Full Text] [Related]
35. VSGs Expressed during Natural T. b. gambiense Infection Exhibit Extensive Sequence Divergence and a Subspecies-Specific Bias towards Type B N-Terminal Domains. So J; Sudlow S; Sayeed A; Grudda T; Deborggraeve S; Ngoyi DM; Desamber DK; Wickstead B; Lejon V; Mugnier MR mBio; 2022 Dec; 13(6):e0255322. PubMed ID: 36354333 [TBL] [Abstract][Full Text] [Related]
36. Field evaluation of the CATT/Trypanosoma brucei gambiense on blood-impregnated filter papers for diagnosis of human African trypanosomiasis in southern Sudan. Chappuis F; Pittet A; Bovier PA; Adams K; Godineau V; Hwang SY; Magnus E; Büscher P Trop Med Int Health; 2002 Nov; 7(11):942-8. PubMed ID: 12390600 [TBL] [Abstract][Full Text] [Related]
37. A spectrum of disease in human African trypanosomiasis: the host and parasite genetics of virulence. Sternberg JM; Maclean L Parasitology; 2010 Dec; 137(14):2007-15. PubMed ID: 20663245 [TBL] [Abstract][Full Text] [Related]
38. First evidence that parasite infecting apparent aparasitemic serological suspects in human African trypanosomiasis are Trypanosoma brucei gambiense and are similar to those found in patients. Kaboré J; Koffi M; Bucheton B; MacLeod A; Duffy C; Ilboudo H; Camara M; De Meeûs T; Belem AM; Jamonneau V Infect Genet Evol; 2011 Aug; 11(6):1250-5. PubMed ID: 21530681 [TBL] [Abstract][Full Text] [Related]
39. Genetic diversity and population structure of Trypanosoma brucei: clonality versus sexuality. Mathieu-Daudé F; Stevens J; Welsh J; Tibayrenc M; McClelland M Mol Biochem Parasitol; 1995 Jun; 72(1-2):89-101. PubMed ID: 8538703 [TBL] [Abstract][Full Text] [Related]
40. Serological tests for gambiense human African trypanosomiasis detect antibodies in cattle. Matovu E; Kitibwa A; Picado A; Biéler S; Bessell PR; Ndung'u JM Parasit Vectors; 2017 Nov; 10(1):546. PubMed ID: 29100526 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]